Par Hyare
2021
In 2021, Par Hyare earned a total compensation of $421.8K as Interim Chief Executive Officer at Sunesis Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $116,668 |
---|---|
Salary | $55,129 |
Other | $250,002 |
Total | $421,799 |
Hyare received $250K in other compensation, accounting for 59% of the total pay in 2021.
Hyare also received $116.7K in non-equity incentive plan and $55.1K in salary.
Rankings
In 2021, Par Hyare's compensation ranked 11,067th out of 12,406 executives tracked by ExecPay. In other words, Hyare earned more than 10.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,067 | 11th |
Manufacturing | 4,878 | 11th |
Chemicals And Allied Products | 2,178 | 8th |
Drugs | 1,938 | 7th |
Pharmaceutical Preparations | 1,432 | 7th |
Hyare's colleagues
We found three more compensation records of executives who worked with Par Hyare at Sunesis Pharmaceuticals in 2021.